IRVINE, Calif., April 6, 2011 /PRNewswire/ -- Life Extension, a global authority on nutrition, health, and wellness and a provider of dietary supplements, has launched a product featuring ChromaDex's (CDXC.OB) pTeroPure pterostilbene, which is now available in many local health food stores and natural retailers.
Life Extension pTeroPure contains 50 mg of pTeroPure pterostilbene, a compound naturally found in blueberries. Pterostilbene has been shown to be superior to a similar compound, resveratrol, which occurs naturally in grapes and is commonly associated with the heart-healthy benefits of red wine. Pterostilbene has a higher potential for cellular uptake due to its better absorption and longer half-life in the blood, properties that may provide enhanced physiological benefits.
ChromaDex's pTeroPure pterostilbene is a 99%-plus pure pterostilbene that is superior to other stilbenes on the market due to its sustainable sourcing and ultra-high purity. ChromaDex was recently presented with the Most Promising Ingredient of the Year award for pTeroPure by Frost & Sullivan, an independent research company.
"pTeroPure continues to make waves in the natural products industry and is an ingredient in more than 17 dietary supplements," remarks Jeremy Bartos, PhD, ChromaDex's pTeroPure Product Manager. "This partnership with Life Extension adds to that growing list and is indicative of the rising demand for this promising ingredient across the industry. We look forward to utilizing Life Extension's market expertise, reputation, and retail influence to increase the presence of pTeroPure in the consumer market."
This product is now available through domestic health and natural food stores and online at http://www.lef.org.
About Life Extension
Life Extension is a global nonprofit research foundation and an authority on nutrition, health and wellness. It provides scientific information on anti-aging and optimal health and produces nutraceuticals for the dietary supplements industry.
ChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an impressive pipeline of new ingredients, including its pTeroPure pterostilbene on which it has worldwide, exclusive patent rights. ChromaDex is a publicly-traded life-sciences company (OTC Bulletin Board: CDXC)
ChromaDex Forward-Looking Statements
Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.
Life Extension Contact
Rey Searles, Director of Marketing
ChromaDex Investor Inquiries:
Liviakis Financial Communications, Inc.
John M. Liviakis, President
Administrative Assistant to the CEO and the President
10005 Muirlands Blvd, Suite G, Irvine, CA 92618